79156199 - V VALNEVA

Information

  • Trademark
  • 79156199
  • Serial Number
    79156199
  • Registration Number
    4774813
  • Filing Date
    July 16, 2014
    10 years ago
  • Registration Date
    July 21, 2015
    9 years ago
  • Transaction Date
    July 21, 2024
    5 months ago
  • Status Date
    August 24, 2021
    3 years ago
  • Published for Opposition Date
    May 05, 2015
    9 years ago
  • Location Date
    August 24, 2021
    3 years ago
  • Status Code
    739
  • Current Location
    GENERIC WEB UPDATE
    Employee Name
    HOLTZ, ALLISON A
  • Attorney Docket Number
    I04222000400
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
3
Mark Identification
V VALNEVA
Case File Statements
  • DM0000: The mark consists of a stylized "V" consisting of three diagonal lines, first light blue, then blue, then light blue, and the word "VALNEVA" in stylized form in dark blue.
  • GS0051: Pharmaceutical products for human and veterinary use for the treatment of auto immune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and pharmaceutical preparations for medical and veterinary use; medical, biological, biotechnological, protein, virological, immunological, bacteriological, chemical, enzymatic and pharmaceutical products, namely, preparation of encapsulated cells which release antibodies for medical and veterinary use; diagnostic products, namely, diagnostic preparations for use in human, veterinary medicine and pharmaceutical use; cell, microorganism or virus cultures for medical and veterinary use; adjuvants for medical or veterinary use; antibiotics, vaccines, viruses, viral vectors, nucleic acids, proteins, recombinant proteins, peptides, peptide antigens, blood serum, antibodies and fragments thereof, and cells for medical, pharmaceutical and veterinary use; viral substances, immunological substances, bacterial substances, enzyme substances used for human and veterinary medicine; diagnostic kits consisting primarily of antibodies and fragments thereof for use in disease testing; diagnostic kits primarily of antibodies and antibody fragments for use in disease testing
  • CC0000: The color(s) light blue, blue, and dark blue is/are claimed as a feature of the mark.
  • GS0011: Chemical products, namely, fungicides, herbicides, insecticides and parasiticides for use in industry, science as well as in agriculture; molecules from bio technologies, namely, proteins in raw material for scientific and medical research; cells for scientific, laboratory or medical research; cell lines for scientific and medical research; nucleic acids for laboratory use; proteins for industrial use; recombinant proteins for industrial use; biomedical compounds, namely, peptides substrates; peptide antigens used in analyzing and detecting certain toxins for research, clinical, medical laboratory use; Biochemical preparations derived from blood serum for use in scientific and medical research; Bio chemicals, namely, antibodies and fragments thereof for in vitro scientific or research use, Chemicals for use in biotechnological product development; cultures of microorganisms other than for medical and veterinary use; viruses, cells, biological, bacteriological or viral preparations, other than for nucleic acids for scientific, laboratory, or medical research
  • GS0421: Scientific research services for medical purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; scientific research for medical, pharmaceutical and veterinary purposes in the fields of auto immune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous systems, cardiovascular diseases, neurodegenerative and chronic diseases; scientific and industrial research, in particular in the fields of biology, cellular and molecular biology, biotechnology, bacteriology, immunology, genetics, gene study, medicine, pharmacology, virology, chemistry; scientific research relating to vaccines, antibiotics and immunological products for human and veterinary use; research and development of new products for others; testing and evaluations of the goods of others to assure compliance with industry standards in the scientific, medical and veterinary fields; research and development of new products for human and veterinary use; scientific research, namely, preparation of scientific experts opinion reports in the scientific, medical and veterinary fields; development and design of laboratory instruments for scientific and industrial research, in particular to obtain and prepare cells, cell lines, viruses, proteins, animal and human materials; development of vaccines, antibiotics and immunological products for human and veterinary use; scientific and technological services, namely, diagnostic and prognostic analyses in the fields of cells, cell lines, animal and human materials, microorganisms, molecules for scientific purposes; scientific research, namely, preparation of scientific expert opinions reports
Case File Event Statements
  • 12/4/2014 - 10 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/8/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/8/2014 - 10 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/23/2015 - 9 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/11/2014 - 10 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/12/2014 - 10 years ago
    5 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/12/2014 - 10 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 12/15/2014 - 10 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/15/2014 - 10 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 1/4/2015 - 9 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/23/2015 - 9 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/23/2015 - 9 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/12/2015 - 9 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 3/12/2015 - 9 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 3/12/2015 - 9 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 3/12/2015 - 9 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 3/12/2015 - 9 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/31/2015 - 9 years ago
    19 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 4/15/2015 - 9 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/15/2015 - 9 years ago
    21 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 4/15/2015 - 9 years ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/2/2015 - 9 years ago
    23 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 5/5/2015 - 9 years ago
    25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/21/2015 - 9 years ago
    26 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/21/2015 - 9 years ago
    27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 12/9/2015 - 9 years ago
    29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 12/22/2016 - 8 years ago
    31 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 3/30/2015 - 9 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 5/5/2015 - 9 years ago
    24 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/9/2015 - 9 years ago
    28 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 1/8/2016 - 8 years ago
    30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/21/2020 - 4 years ago
    34 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 8/24/2021 - 3 years ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 12/13/2018 - 6 years ago
    32 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 9/26/2019 - 5 years ago
    33 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/13/2021 - 3 years ago
    35 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 6/7/2024 - 6 months ago
    40 - INTERNATIONAL REGISTRATION RENEWED Type: RNWL
  • 8/24/2021 - 3 years ago
    37 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A
  • 8/24/2021 - 3 years ago
    38 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75
  • 10/15/2022 - 2 years ago
    39 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 7/21/2024 - 5 months ago
    41 - COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED Type: REM4